A MULTICENTER, OPEN-LABEL, SINGLE ARM STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SPARSENTAN IN POSTTRANSPLANT IMMUNOGLOBULIN A NEPHROPATHY (IGAN) OR FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

Project: Research project

Project Details

StatusActive
Effective start/end date12/16/25 → 12/15/29

Funding

  • Travere Therapeutics Inc ( Award # ): $29,000.00